This treatment is designed to support energy levels, mental clarity, and metabolic health through a clinically guided approach
Al-Aly, Z., Maddukuri, G
Sanofis GLP-1 Strategy Sanofis first try at a GLP-1 drug was in the obesity indication
In laboratory settings, the combination has been studied for its dual interaction with GHRH and ghrelin pathways, with investigations focusing on receptor binding, signaling, and the modulation of hormone dynamics
Research suggests it promotes blood-vessel growth, supports tissue repair, and modulates inflammation, particularly in the gastrointestinal tract
Energy, Focus & Performance Our signature Myers Cocktail and NAD+ IV treatments help restore energy, sharpen focus, and support physical endurance